E-clinic startup CureBay in India has bagged $21 million in a Collection B investment spherical led by means of Bertelsmann India Funding. Elevar Fairness and British World Funding additionally joined the fundraising match.
Since launching in 2021, the corporate now has a series of over 150 rural e-clinics around the states of Odisha and Chhattisgarh, using over 1,000 neighborhood well being employees, or Swasthya Mitras, who’re skilled to facilitate teleconsultations, diagnostic exams, drugs order and supply, and medical institution admission and concierge products and services. CureBay provides a preventive well being provider bundle to which round 90,000 are actively subscribed.
WHAT IT’S FOR
With its recent budget, CureBay plans to deploy proprietary AI-powered algorithms to allow workflow automation and toughen the predictive features of its rural e-clinic community. The startup has already built-in gadget studying, generative AI, and Web of Issues diagnostics into its generation platform.
“The capital will assist us scale generation, ability, and succeed in to carry dignified, inexpensive healthcare to the ultimate mile,” added founder and CEO Priyadarshi Mohapatra.
CureBay raised greater than $13 million in Collection A investment in two rounds during the last 3 years to construct its community. It objectives to arrange 200 e-clinics in rural India.
MARKET SNAPSHOT
Indian well being tech startups growing or integrating AI into their generation stack have attracted essentially the most investments lately. As an example, scientific imaging startup Qure.ai raised $65 million in Collection D investment in September, whilst dermatology startup Cureskin raked in $20 million in Collection B investment in March ultimate yr.
Dozee, which provides an AI-powered contactless important indicators tracking and alert device, seeks to go into extra world markets with its newest $8 million funding.
Kauvery Medical institution, via its making an investment arm, Healthcare Capital, supplied undisclosed investment to far off affected person tracking device developer Lifesigns to assist increase its AI and predictive set of rules features.
Early this yr, BrainSight AI, which develops an AI-powered mind mapping platform, scored $5 million in pre-Collection A investment, whilst Consint.AI, which provides generative AI-driven insurance coverage generation answers, raised $500,000 in seed investment.
